Molnupiravir not to be included in Covid treatment now

The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now,......

UK's new antibody treatment against Covid may work against Omicron

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron. IMAGE: A nurse prepares......

Pressure on UK to review Covid vax rules for Indians

The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to......

Novovax Covid vaccine likely to get nod in India ahead of US

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......

Alkem fudged trial data: German regulator

The European Medicines Agency’s review is the second setback to Alkem Laboratories. Alkem Laboratories has been accused by Germany’s health regulator of fudging data on clinical trials......

Markets end lower amid weak global cues

IT majors Infosys and TCS were the top losers while capital goods shares BHEL and L&T ended firm on robust core sector growth. Despite a marginal recovery in late trades benchmark share indices......

Wockhardt to recall some drugs made in India

Pharmaceuticals major Wockhardt is recalling select drugs in the US, manufactured at its two units at Chikalthana and Waluj in Maharashtra, which were under import restrictions from the USFDA.......

Pharma in 2014: Deals worth billions and fines worth millions

Even as private firms were busy stitching merger and partnership deals, the government also remained active during the year working on a separate policy to promote and strengthen domestic......